Tuo Deng

735 total citations
20 papers, 416 citations indexed

About

Tuo Deng is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Tuo Deng has authored 20 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Surgery and 8 papers in Cancer Research. Recurrent topics in Tuo Deng's work include Pancreatic and Hepatic Oncology Research (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Cancer-related molecular mechanisms research (5 papers). Tuo Deng is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Cancer-related molecular mechanisms research (5 papers). Tuo Deng collaborates with scholars based in China, Australia and United States. Tuo Deng's co-authors include Gang Chen, Yi Wang, Keqing Shi, Liming Deng, Haitao Yu, Tan Zhang, Mengtao Zhou, Zhengping Yu, Yukai Xiang and Yunfeng Shan and has published in prestigious journals such as Oncogene, Free Radical Biology and Medicine and Cell Death and Disease.

In The Last Decade

Tuo Deng

19 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tuo Deng China	12	229	111	105	103	75	20	416
Muhammad Talal Sarmini United States	8	142 0.6×	108 1.0×	181 1.7×	102 1.0×	98 1.3×	29	473
Alessio Degiovanni Italy	12	121 0.5×	53 0.5×	107 1.0×	85 0.8×	70 0.9×	23	345
Qianru Li China	10	135 0.6×	73 0.7×	148 1.4×	107 1.0×	74 1.0×	26	394
Wencheng Kong China	11	195 0.9×	73 0.7×	90 0.9×	110 1.1×	152 2.0×	33	435
Nanzheng Chen China	13	191 0.8×	202 1.8×	139 1.3×	139 1.3×	99 1.3×	29	495
Zhaoyang Lu China	9	179 0.8×	68 0.6×	49 0.5×	70 0.7×	85 1.1×	14	361
Yifeng Tao China	14	190 0.8×	99 0.9×	90 0.9×	81 0.8×	105 1.4×	37	512
Zhaoyan Qiu China	13	229 1.0×	162 1.5×	119 1.1×	108 1.0×	115 1.5×	18	496
Junko Kishikawa Japan	14	115 0.5×	115 1.0×	175 1.7×	45 0.4×	45 0.6×	36	442
Lijin Zhao China	13	155 0.7×	109 1.0×	95 0.9×	55 0.5×	102 1.4×	47	388

Countries citing papers authored by Tuo Deng

Since Specialization

Citations

This map shows the geographic impact of Tuo Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuo Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuo Deng more than expected).

Fields of papers citing papers by Tuo Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tuo Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuo Deng. The network helps show where Tuo Deng may publish in the future.

Co-authorship network of co-authors of Tuo Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Tuo Deng. A scholar is included among the top collaborators of Tuo Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tuo Deng. Tuo Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Tinghong, Yulong Han, Yaofeng Wang, et al.. (2025). Dual roles of LMO2 in promoting tumor angiogenesis and progression. 1(3). 100024–100024.

Tang, Yuan, et al.. (2024). Unraveling Crucial Mitochondria-Related Genes in the Transition from Ulcerative Colitis to Colorectal Cancer. Drug Design Development and Therapy. Volume 18. 3175–3189. 1 indexed citations

Lü, Fei, Jinhuan Yang, Haitao Yu, et al.. (2023). Gut microbiome as a biomarker for predicting early recurrence of HBV‐related hepatocellular carcinoma. Cancer Science. 114(12). 4717–4731. 19 indexed citations

Deng, Liming, Wenming Bao, Baofu Zhang, et al.. (2023). AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway. Cell Death and Disease. 14(9). 590–590. 8 indexed citations

Chen, Jin, Rui Li, Tuo Deng, et al.. (2022). Association between dried fruit intake and pan-cancers incidence risk: A two-sample Mendelian randomization study. Frontiers in Nutrition. 9. 899137–899137. 16 indexed citations

Deng, Tuo, Bo Chen, Fangting Liu, et al.. (2022). Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer. Hepatology International. 16(1). 99–111. 41 indexed citations

Yang, Jinhuan, Yi Wang, Xiaotian Chen, et al.. (2022). Laparoscopic Versus Open Surgery for Early-Stage Intrahepatic Cholangiocarcinoma After Mastering the Learning Curve: A Multicenter Data-Based Matched Study. Frontiers in Oncology. 11. 742544–742544. 10 indexed citations

Yang, Jinhuan, Kaiwen Chen, Kaiyu Chen, et al.. (2022). Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma. Journal of Cachexia Sarcopenia and Muscle. 13(5). 2383–2392. 39 indexed citations

Zhang, Tan, Sina Zhang, Jin Chen, et al.. (2021). A Predictive Model Based on the Gut Microbiota Improves the Diagnostic Effect in Patients With Cholangiocarcinoma. Frontiers in Cellular and Infection Microbiology. 11. 751795–751795. 44 indexed citations

10.

Wang, Yi, Haitao Yu, Xiaozai Xie, et al.. (2021). Plasmalemma vesicle-associated protein promotes angiogenesis in cholangiocarcinoma via the DKK1/CKAP4/PI3K signaling pathway. Oncogene. 40(25). 4324–4337. 26 indexed citations

11.

Chen, Ziyan, Haitao Yu, Lijun Wu, et al.. (2021). Identification and Validation of Hub Genes Predicting Prognosis of Hepatocellular Carcinoma. Digestive Surgery. 39(1). 24–31. 1 indexed citations

12.

Zhang, Jie, Weiguo Huang, Qikuan He, et al.. (2021). PINK1/PARK2 dependent mitophagy effectively suppresses NLRP3 inflammasome to alleviate acute pancreatitis. Free Radical Biology and Medicine. 166. 147–164. 22 indexed citations

13.

Deng, Liming, Bo Chen, Haitao Yu, et al.. (2021). A Novel Clinical-Radiomics Model Based on Sarcopenia and Radiomics for Predicting the Prognosis of Intrahepatic Cholangiocarcinoma After Radical Hepatectomy. Frontiers in Oncology. 11. 744311–744311. 13 indexed citations

14.

Deng, Tuo, Bingren Hu, Jin Chen, et al.. (2021). A novel ferroptosis phenotype‐related clinical‐molecular prognostic signature for hepatocellular carcinoma. Journal of Cellular and Molecular Medicine. 25(14). 6618–6633. 24 indexed citations

15.

Deng, Tuo, Jin Chen, Kaiyu Chen, et al.. (2021). Identification and validation of a glycolysis-associated multiomics prognostic model for hepatocellular carcinoma. Aging. 13(5). 7481–7498. 10 indexed citations

16.

Shi, Zhehao, Yi Wang, Wen Ye, et al.. (2020). The LipoxinA4 receptor agonist BML-111 ameliorates intestinal disruption following acute pancreatitis through the Nrf2-regulated antioxidant pathway. Free Radical Biology and Medicine. 163. 379–391. 26 indexed citations

17.

Huang, Weiguo, Yi Zhou, Tuo Deng, et al.. (2020). A novel molecular-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma. Aging. 12(13). 12896–12920. 4 indexed citations

18.

Shi, Keqing, Kai Qi, Hongru Kong, et al.. (2019). Natural Killer Cell-Derived Exosomal miR-3607-3p Inhibits Pancreatic Cancer Progression by Targeting IL-26. SSRN Electronic Journal. 8 indexed citations

19.

Zhang, Jie, Keqing Shi, Weiguo Huang, et al.. (2019). The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma. Cancer Cell International. 19(1). 107–107. 13 indexed citations

20.

Xiang, Yukai, Wen Ye, Chaohao Huang, et al.. (2018). Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway. Oxidative Medicine and Cellular Longevity. 2018(1). 2360427–2360427. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact